Too Heng-Phon
Founder at Mirxes Holding Co., Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Zhou Lihan | M | 40 |
Mirxes Holding Co., Ltd.
 Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore.
Ark Bio Holding Pte Ltd.
 Ark Bio Holding Pte Ltd. Financial ConglomeratesFinance Ark Bio Holding Pte Ltd. operates as an investment holding company. The firm offers end-to-end solutions focused on cancer early detection. The company was founded by Isaac Ho, Zhou Lihan and Zou Ruiyang in 2018 and is headquartered in Singapore. | 10 years |
| Zou Ruiyang | M | 38 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore.
Ark Bio Holding Pte Ltd.
Ark Bio Holding Pte Ltd. Financial ConglomeratesFinance Ark Bio Holding Pte Ltd. operates as an investment holding company. The firm offers end-to-end solutions focused on cancer early detection. The company was founded by Isaac Ho, Zhou Lihan and Zou Ruiyang in 2018 and is headquartered in Singapore. | 10 years |
| Isaac Ho | M | - |
Ark Bio Holding Pte Ltd.
Ark Bio Holding Pte Ltd. Financial ConglomeratesFinance Ark Bio Holding Pte Ltd. operates as an investment holding company. The firm offers end-to-end solutions focused on cancer early detection. The company was founded by Isaac Ho, Zhou Lihan and Zou Ruiyang in 2018 and is headquartered in Singapore. | 6 years |
| Hou Chiat Ho | M | 48 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore.
Ark Bio Holding Pte Ltd.
Ark Bio Holding Pte Ltd. Financial ConglomeratesFinance Ark Bio Holding Pte Ltd. operates as an investment holding company. The firm offers end-to-end solutions focused on cancer early detection. The company was founded by Isaac Ho, Zhou Lihan and Zou Ruiyang in 2018 and is headquartered in Singapore. | 6 years |
| Lee Meng Lim | M | 68 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 years |
| Tai San Noah Lim | M | 49 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 years |
| Lo Ling Ma | F | 39 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | - |
| Beng Lor Choo | M | 52 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 4 years |
| Yuet Chew Siow | F | 57 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 1 years |
| Da Liu | M | 53 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 years |
| Beilin Le | M | 35 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 years |
| Wei Zhi Owyong | F | - |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Yan Cheong Chan | M | 71 |
Imperial College London
| 9 years |
| Gordon Ng | M | 59 |
University of London
| 5 years |
| Kang Bor Lee | M | 70 |
University of London
| 6 years |
| John David Salter | M | 66 |
Imperial College London
| 8 years |
| Shiu Kin Yeung | M | 65 |
Imperial College London
| 5 years |
| Hussam bin Saud Al-Saud | M | 64 |
University of London
| 4 years |
| Kian Min Ong | M | 63 |
Imperial College London
University of London
| 8 years |
| Tet Foh Wong | M | 63 |
Imperial College London
| 5 years |
| Amr Ali Baghdadi | M | - |
Imperial College London
| 5 years |
| Mohammad Zaidi | M | - |
Imperial College London
| 4 years |
| Cory Gelmon | M | 64 |
University of London
| 3 years |
| Mohamed Hazlan bin Mohamed Hussain | M | - |
University of London
| 4 years |
| Peter Davies | M | - |
University of London
| 4 years |
| Sanjay Patel | M | - |
University of London
| 4 years |
| Bradley Peter Mulroney | M | 61 |
University of London
| 4 years |
| Angie Gawreletz | F | - |
University of London
| 4 years |
| Timothy Wright | M | 63 |
University of London
| 3 years |
| Wing Cheung Wong | M | - |
University of London
| 3 years |
| Hugh F. Durrant-Whyte | M | - |
University of London
| 4 years |
| Rachel Kyte | F | - |
University of London
| 3 years |
| Ahmad bin Abdullah | M | 60 |
University of London
| 3 years |
| A. K. M. Sadrul Islam | M | 69 |
University of London
| 3 years |
| Yuk Fan Choi | M | 71 |
University of London
| 3 years |
| Su Lin Chong | M | 63 |
University of London
| 3 years |
| Emil Moskofian | M | - |
University of London
| 4 years |
| W. M. H. Jaim | M | - |
University of London
| 3 years |
| Zaini bin Omar | M | 74 |
University of London
| 3 years |
| Swee Long Liu | M | 63 |
University of London
| 3 years |
| Yiu Tim Ma | M | 69 |
University of London
| 3 years |
| Wang Kwong Luk | M | 79 |
University of London
| 3 years |
| Chi Wang Lau | M | 76 |
University of London
| 4 years |
| Hon Wan Chan | M | 67 |
University of London
| 3 years |
| Ngai Man Ng | M | 62 |
University of London
| 4 years |
| Kwok Kee Lau | M | 64 |
University of London
| 3 years |
| Harikrishna Kulaveerasingam | M | 63 |
University of London
| 4 years |
| Ching Wan Lam | M | 66 |
University of London
| 3 years |
| Ban Leong Tan | M | 62 |
University of London
| 1 years |
| Anthony Couse | M | 58 |
University of London
| 3 years |
| Melanie Braunold | F | - |
University of London
| 3 years |
| Koon Man Chung | M | 65 |
University of London
| 4 years |
| Jayne O’Brien | F | - |
University of London
| 4 years |
| Man Shing Chi | M | 60 |
University of London
| 4 years |
| Christopher Martin Nutting | M | - |
University of London
| 4 years |
| Glaucius Oliva | M | - |
University of London
| 3 years |
| Kim Hung Leung | M | 63 |
University of London
| 3 years |
| Kock Hooi Lim | M | 67 |
University of London
| 3 years |
| Bing Hua Tan | M | 79 |
University of London
| 3 years |
| King Yan To | M | 65 |
University of London
| 3 years |
| Murelidaran M. Navaratnam | M | 58 |
University of London
| 3 years |
| Siu Wah Chung | M | 67 |
University of London
| 3 years |
| Jeremy Longley | M | 57 |
University of London
| 4 years |
| Douglas Deighton | M | - |
University of London
| 4 years |
| Bolaji Odunsi | M | 62 |
University of London
| 4 years |
| Michael Williams | M | - |
University of London
| 3 years |
| John-Mark Coates | M | 63 |
University of London
| 4 years |
| Harren Jhoti | M | 61 |
University of London
| 4 years |
| Anthony W. Fox | M | - |
University of London
| 3 years |
| Christopher Charles Warkup | M | - |
University of London
| 4 years |
| Rifat Atun | M | - |
University of London
| 5 years |
| J. D. Weinberg | M | - |
University of London
| 4 years |
| Vanessa K. Blackmore | F | - |
University of London
| 3 years |
| Ting Yeung Fok | M | 75 |
University of London
| 3 years |
| Ming Tung Ko | M | 63 |
University of London
| 3 years |
| Hon Tak Ng | M | 64 |
University of London
| 4 years |
| Franky Tjahyadikarta | M | 67 |
Imperial College London
| 1 years |
| Christopher James David Lees | M | - |
University of London
| 4 years |
| Sanjiv Pandya | M | - |
University of London
| 1 years |
| Timothy David Voake | M | - |
University of London
| 4 years |
| Loga Bala Mohan Jaganathan | M | 58 |
University of London
| 3 years |
| Iain Green | M | - |
University of London
| 3 years |
| Kin Hung Lam | M | 67 |
University of London
| 6 years |
| Chung Wing Lai | M | 77 |
University of London
| 3 years |
| Ron Olivier | M | - |
University of London
| 4 years |
| Chee Keong Tan | M | - |
University of London
| 4 years |
| Tan Chee Keong | M | - |
University of London
| 4 years |
| Mark Seymour | M | - |
University of London
| 3 years |
| Ka Hing Wong | M | 63 |
University of London
| 4 years |
| Michael Joseph Ezra Sternberg | M | - |
University of London
| 5 years |
| Charlie Rudd | M | - |
University of London
| 4 years |
| Stefan Ogrodzinski | M | 60 |
University of London
| 4 years |
| Siak Hee Tan | M | 69 |
University of London
| 4 years |
| Paul Castella | M | - |
University of London
| 3 years |
| Alex Renny | M | 62 |
University of London
| 4 years |
| Manish Thakur | M | - |
University of London
| 3 years |
| Brian Sean Padgett | M | 57 |
University of London
| 4 years |
| Kemal Malik | M | 61 |
University of London
| 4 years |
| Andy Reed | M | - |
University of London
| 4 years |
| Mohd Noor Bin Awang | M | 70 |
University of London
| 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 88 | 88.00% |
| Singapore | 12 | 12.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Too Heng-Phon
- Personal Network
